Articles tagged "Kidney transplantation"

2017 American Transplant Congress
National Variation in US Kidney Transplant Induction Therapy.
V. Dharnidharka,¹ A. Naik,² T. Alhamad,¹ D. Axelrod,³ M. Schnitzler,^4,6 Z. Zhang,⁴ S. Bae,⁵ D. Brennan,¹ D. Segev,⁵ H. Randall,⁴ M. Nazzal,⁴ R. Ouseph,⁴ B. Kasiske,⁶ K. Lentine.⁴
¹Washington Univ, St. Louis, MO; ²U Michigan, Ann Arbor, MI; ³East Carolina Univ, Greenville, NC; ⁴St. Louis Univ, St. Louis, MO; ⁵Johns Hopkins, Baltimore, MD; ⁶Scientific Registry of Transplant Recipients, Minneapolis, MN
Antibody induction (IND) therapy in kidney transplantation (KTx) reduces acute rejection risk but adds to transplant cost. Currently, only IL2 Receptor antibodies (IL2R-Ab) have FDA…
2017 American Transplant Congress
Improved Mouse Renal Transplantation Model Simulating Clinical Antibody Mediated Rejection.
D. Zhao, S. Li, T. Liao, X. Hua, F. Han, Z. Luo, X. Liu, Q. Sun.
Kidney Transplantation, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Background: Acute antibody mediated rejection (AMR) is main barrier to long term renal graft survival. Mouse model is important to understand the mechenisms of AMR.…
2017 American Transplant Congress
Prophylactic Therapy Against Multidrug-Resistant Acinetobacter baumannii Contamination of Preservation Solution in Renal Transplantation: A Single Center Experience.
R. Wang, J. Zhou, J. Wu.
Kidney Disease Center, the First Affiliated Hospital, Zhejiang University, Hangzhou, China
Objectives: Rapidly increased multiple drug resistant (MDR) gram negative bacilli like Acinetobacter baumannii (AB) become the main pathogen in ICU nowdays. Our study is intended…
2017 American Transplant Congress
Substance Use Among Potential Kidney Transplant Candidates and Its Impact on Access to Kidney Transplantation; a Canadian Cohort Study.
E. Tang,¹ A. Bansal,¹ M. Kwok,¹ O. Famure,¹ S. Kim,¹ D. Buchman,² M. Novak,³ I. Mucsi.¹
¹Multiorgan Transplant Program, University Health Network, Toronto, ON, Canada; ²Department of Bioethics, University Health Network, Toronto, ON, Canada; ³Department of Psychiatry, University Health Network, Toronto, ON, Canada
We assessed 1) the prevalence and associations of substance use among patients undergoing evaluation for kidney transplant (KT); 2) the association between substance use and…
2017 American Transplant Congress
Assessments of Literacy, Cognitive Function and Transplant Medication Knowledge in Renal Transplant Recipients.
J. Trofe-Clark,¹ W. Gbemudu,² S. Ryan,² D. Sawinski,¹ M. Lim,¹ S. Goral,¹ M. Bleicher,¹ R. Bloom,¹ P. Reese.¹
¹Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia; ²Hosp. of Univ. of Pennsylvania, Philadelphia
Background: Medication adherence is often low in renal transplant recipients (RTR) and is in part due to inadequate knowledge. Therefore, new tools to identify medication…
2017 American Transplant Congress
Building a Conceptual Framework of Treatment Burden After Kidney Transplant: A Qualitative Study.
E. Lorenz, J. Egginton, M. Stegall, A. Cheville, D. Eton.
Mayo Clinic, Rochester
Background: After kidney transplant, patients must negotiate complex medication regimens, lifestyle changes, laboratory monitoring and clinic appointments. The personal workload of healthcare and its impact…
2017 American Transplant Congress
Transplant Professionals' Attitudes and Approaches to the Living Kidney Donor-Recipient Relationship: Interview Study.
A. Ralph,^1,2,3 P. Butow,^3,4,5 J. Craig,^1,2 J. Chapman,⁸ J. Gill,⁶ J. Kanellis,⁷ A. Tong.^1,2
¹Sydney School of Public Health, University of Sydney, Sydney, Australia; ²Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia; ³School of Psychology, University of Sydney, Sydney, Australia; ⁴Psycho-Oncology Co-Operative Research Group, University of Sydney, Sydney, Australia; ⁵Centre for Medical Psychology & Evidence-Based Decision-Making, University of Sydney, Sydney, Australia; ⁶Division of Nephrology, University of British Columbia, Vancouver, Canada; ⁷Department of Nephrology, Monash Health and Centre for Inflammatory Diseases, Department of Medicine, Monash University, Melbourne, Australia; ⁸Centre for Transplant and Renal Research, University of Sydney, Sydney, Australia
Background: Assessment of the donor-recipient relationship is recommended by international guidelines to prevent undue coercion and ensure realistic expectations. We aimed to describe attitudes and…
2017 American Transplant Congress
Identification of Plasma Protein Biomarkers of Acute Renal Allograft Rejection.
M. Rossetti,¹ C. Fitzpatrick,¹ N. Harre,¹ Y. Zheng,¹ N. Mercer,² G. Sunga,¹ D. Gjertson,¹ E. Reed.¹
¹Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; ²Department of Biostatistics, University of California Los Angeles, Los Angeles, CA
Background & Aim: Upon presentation of clinical symptoms, renal transplant recipients routinely undergo needle core biopsy to diagnose acute graft rejection. This procedure is invasive…
2017 American Transplant Congress
Focal Segmental Glomerulosclerosis Recurrence in Renal Transplant Recipients Treated with Belatacept.
W. Kitchens, A. Farris, S. Pastan, T. Pearson, C. Larsen, A. Adams.
Emory Transplant Center, Atlanta, GA
Introduction: Focal segmental glomerulosclerosis (FSGS) is a cause of end-stage renal failure that frequently recurs following renal transplant, often leading to allograft loss. A recently…
2017 American Transplant Congress
Steroid Withdrawal Using Everolimus in Maintenance Kidney Transplant Recipients with Post-Transplant Diabetes Mellitus.
K. Nanmoku, A. Kurosawa, T. Kubo, T. Shinzato, T. Shimizu, T. Kimura, T. Yagisawa.
Surgical Branch, Institute of Kidney Diseases, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
Background: Although steroid withdrawal from conventional immunosuppressive therapy has been attempted to ameliorate various complications, especially diabetes mellitus (DM), in kidney transplant recipients, a steroid-sparing…